Drug Search Results
More Filters [+]

Galidesivir

Alternative Names: galidesivir, bcx-4430, bcx4430, bcx 4430
Latest Update: 2024-03-23
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: ADORA Analogue

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: BioCryst
Company Location: DURHAM NC 27703
Company CEO: Jon P. Stonehouse
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Galidesivir

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Hemorrhagic Fever, Ebola|Communicable Diseases|Filoviridae Infections|COVID-19|Yellow Fever|Marburg Virus Disease

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

BCX4430-108

P1

Terminated

Yellow Fever|COVID-19

2021-01-31

22%

BCX4430-106

P1

Completed

Marburg Virus Disease

2019-04-30

BCX4430-101

P1

Completed

Hemorrhagic Fever, Ebola|Filoviridae Infections|Communicable Diseases

2016-03-01

Recent News Events